Your browser doesn't support javascript.
loading
Nanofluidic drug-eluting seed for sustained intratumoral immunotherapy in triple negative breast cancer.
Chua, Corrine Ying Xuan; Jain, Priya; Susnjar, Antonia; Rhudy, Jessica; Folci, Marco; Ballerini, Andrea; Gilbert, April; Singh, Shailbala; Bruno, Giacomo; Filgueira, Carly S; Yee, Cassian; Butler, E Brian; Grattoni, Alessandro.
Afiliação
  • Chua CYX; Department of Nanomedicine, Houston Methodist Research Institute (HMRI), Houston, TX, USA.
  • Jain P; Department of Nanomedicine, Houston Methodist Research Institute (HMRI), Houston, TX, USA.
  • Susnjar A; Department of Nanomedicine, Houston Methodist Research Institute (HMRI), Houston, TX, USA.
  • Rhudy J; Department of Nanomedicine, Houston Methodist Research Institute (HMRI), Houston, TX, USA.
  • Folci M; Department of Allergy and Clinical Immunology, Istituto Auxologico Italiano, University of Milan, Milan, Italy.
  • Ballerini A; Department of Nanomedicine, Houston Methodist Research Institute (HMRI), Houston, TX, USA; Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
  • Gilbert A; Department of Nanomedicine, Houston Methodist Research Institute (HMRI), Houston, TX, USA.
  • Singh S; Department of Melanoma Medical Oncology, University of MD Anderson Cancer Center, Houston, TX, USA.
  • Bruno G; Department of Nanomedicine, Houston Methodist Research Institute (HMRI), Houston, TX, USA; Politecnico di Torino, Turin, Italy.
  • Filgueira CS; Department of Nanomedicine, Houston Methodist Research Institute (HMRI), Houston, TX, USA.
  • Yee C; Department of Melanoma Medical Oncology, University of MD Anderson Cancer Center, Houston, TX, USA.
  • Butler EB; Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX, USA.
  • Grattoni A; Department of Nanomedicine, Houston Methodist Research Institute (HMRI), Houston, TX, USA; Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX, USA; Department of Surgery, Houston Methodist Hospital, Houston, TX, USA. Electronic address: agrattoni@houstonmethodist.org.
J Control Release ; 285: 23-34, 2018 09 10.
Article em En | MEDLINE | ID: mdl-30008369
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistemas de Liberação de Medicamentos / Implantes de Medicamento / Neoplasias de Mama Triplo Negativas / Antineoplásicos Imunológicos / Imunoterapia Limite: Animals Idioma: En Revista: J Control Release Assunto da revista: FARMACOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistemas de Liberação de Medicamentos / Implantes de Medicamento / Neoplasias de Mama Triplo Negativas / Antineoplásicos Imunológicos / Imunoterapia Limite: Animals Idioma: En Revista: J Control Release Assunto da revista: FARMACOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos